Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort

Open access

Abstract

Background: Heart failure (HF) is a growing complication and one of the leading causes of mortality in people living with type 2 diabetes (T2D). Among the possible causes, the excess of red meat and the insufficiency of vegetables consumption are suspected. Such an alimentation is associated with nutritional biomarkers, including trimethylamine N -oxide (TMAO) and its precursors. Here, we aimed to study these biomarkers as potential prognostic factors for HF in patients with T2D. Methods: We used the SURDIAGENE (SURvival DIAbetes and GENEtics) study, a large, prospective, monocentric cohort study including 1468 patients with T2D between 2001 and 2012. TMAO and its precursors (trimethylamine [TMA], betaine, choline, and carnitine) as well as thio-amino-acids (cysteine, homocysteine and methionine) were measured by liquid chromatography-tandem mass spectrometry. The main outcome was HF requiring Hospitalization (HFrH) defined as the first occurrence of acute HF leading to hospitalization and/or death, established by an adjudication committee, based on hospital records until 31st December 2015. The secondary outcomes were the composite event HFrH and/or cardiovascular death and all-cause death. The association between the biomarkers and the outcomes was studied using cause-specific hazard-models, adjusted for age, sex, history of coronary artery disease, NT-proBNP, CKD-EPI-derived eGFR and the urine albumin/creatinine ratio. Hazard-ratios (HR) are expressed for one standard deviation. Results: The data of interest were available for 1349/1468 of SURDIAGENE participants (91.9%), including 569 (42.2%) women, with a mean age of 64.3 ± 10.7 years and a median follow-up of 7.3 years [25th–75th percentile, 4.7–10.8]. HFrH was reported in 209 patients (15.5%), HFrH and/or cardiovascular death in 341 (25.3%) and all-cause death in 447 (33.1%). In unadjusted hazard-models, carnitine (HR = 1.20, 95% CI [1.05; 1.37]), betaine (HR = 1.34, [1.20; 1.50]), choline (HR = 1.35, [1.20; 1.52]), TMAO (HR = 1.32, [1.16; 1.50]), cysteine (HR = 1.38, [1.21; 1.58]) and homocysteine (HR = 1.28, [1.17; 1.39]) were associated with HFrH, but not TMA and methionine. In the fully adjusted models, none of these associations was significant, neither for HFrH nor for HFrH and/or CV death, when homocysteine only was positively associated with all-cause death (HR = 1.16, [1.06; 1.27]). Conclusions: TMAO and its precursors do not appear to be substantial prognosis factors for HFrH, beyond usual cardiac- and kidney-related risk factors, whereas homocysteine is an independent risk factor for all-cause death in patients with T2D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-022-01505-9

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study flow-chart. CKD: Chronic Kidney Disease; CV: Cardiovascular; HFrH: Heart Failure requiring Hospitalization, defined as the first occurrence of acute HF leading to hospitalization and/or death; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; TMAO: trimethylamine N-oxide
Fig. 1 Study flow-chart. CKD: Chronic Kidney Disease; CV: Cardiovascular; HFrH: Heart Failure requiring Hospitalization, defined as the first occurrence of acute HF leading to hospitalization and/or death; NT-proBNP: N-terminal prohormone of brain natriuretic peptide; TMAO: trimethylamine N-oxideCC BY · PubMed Central
Fig. 2 Cumulative Incidence Function for HFrH. Quartile values for the different parameters of interest: carnitine (median = 42.6, [25th–75th] percentile = [35.4–50.7]); betaine (31.5, [24.6–38.9]); choline (1.43, [1.22–1.68]); TMAO (6.8, [4.2–12.8]); cysteine (23, [13–39]); homocysteine (8.9, [4.7–14.8]). HFrH: Heart Failure requiring Hospitalization, defined as the first occurrence of acute HF leading to hospitalization and/or death; TMAO: trimethylamine N-oxide
Fig. 2 Cumulative Incidence Function for HFrH. Quartile values for the different parameters of interest: carnitine (median = 42.6, [25th–75th] percentile = [35.4–50.7]); betaine (31.5, [24.6–38.9]); choline (1.43, [1.22–1.68]); TMAO (6.8, [4.2–12.8]); cysteine (23, [13–39]); homocysteine (8.9, [4.7–14.8]). HFrH: Heart Failure requiring Hospitalization, defined as the first occurrence of acute HF leading to hospitalization and/or death; TMAO: trimethylamine N-oxideCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. IDF Atlas 9th edition and other resources [Internet]. https://diabetesatlas.org/en/resources/. Accessed 30 Apr 2021.

Cited by

See all 21

Metadata

Authors
Wargny, M., Croyal, M., Ragot, S., Gand, E., Jacobi, D., Trochu, J.-N., Prieur, X., Le May, C., Goronflot, T., Cariou, B., Saulnier, P.-J., Hadjadj, S., for the SURDIAGENE study group, Marechaud, R., Javaugue, V., Hulin-Delmotte, C., Llatty, P., Ducrocq, G., Roussel, R., Rigalleau, V., Pucheu, Y., Montaigne, D., Halimi, J.-M., Gatault, P., Sosner, P., & Gellen, B.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • Centre Hospitalier Universitaire de Poitiers (FR)
  • Centre Hospitalier Universitaire de Nantes (FR)
Corresponding author
Hadjadj, Samy
Venue
Cardiovascular Diabetology
Published
2022-06-09
Volume
21
Issue
1
Pages
101-101
ISSN
1475-2840 (ISSN-L)
OpenAlex
W4281654645
Cited by
21
References
32
Citations by year
2026: 6 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 2
FWCI
2.61
Type
journal article
Language
en
Open access
Licence
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Fondation de France
  • Société Francophone du Diabète
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
heart failure hospitalization, type 2 diabetes, trimethylamine N-oxide, trimethylamine, L-carnitine, thiamine, thiamine pyrophosphate, dietary biomarkers, prognostic factors, cardiovascular mortality, all-cause mortality, vegetable consumption, thiamine deficiency
MeSH terms
Aged, Betaine, Carnitine, Choline, Cysteine, Diabetes Mellitus, Type 2, Female, Heart Failure, Homocysteine, Hospitalization, Humans, Male, Methionine, Middle Aged, Prospective Studies, Risk Factors, Cohort Studies, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort. https://app.cochat.ai/papers/10.1186/s12933-022-01505-9
The paper
Wargny, M., Croyal, M., Ragot, S., Gand, E., Jacobi, D., Trochu, J.-N., Prieur, X., Le May, C., Goronflot, T., Cariou, B., Saulnier, P.-J., Hadjadj, S., for the SURDIAGENE study group, Marechaud, R., Javaugue, V., Hulin-Delmotte, C., Llatty, P., Ducrocq, G., Roussel, R., . . . Gellen, B. (2022). Nutritional biomarkers and heart failure requiring hospitalization in patients with type 2 diabetes: the SURDIAGENE cohort. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-022-01505-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.